Like this:
• The maximum tolerated dose established in these studies is significantly higher than
doses to be used in the Phase 1 clinical trial, thereby reducing the likelihood of an
adverse event occurring during the Phase 1 trial.
Ann: Maximum Tolerated Dose Successfully Established in Studies, page-2
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.0¢ |
Change
0.015(2.13%) |
Mkt cap ! $92.22M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 72.0¢ | 68.5¢ | $45.51K | 64.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1128 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 54923 | 3 |
View Market Depth
| Last trade - 15.55pm 08/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |